Yatomi Y, Arata Y, Tada S, Kume S, Ui M
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Eur J Biochem. 1992 May 1;205(3):1003-9. doi: 10.1111/j.1432-1033.1992.tb16867.x.
Increases in the intracellular Ca2+ concentration of human platelets caused by receptor agonists, such as thrombin, 9,11-epithio-11,12-methanothromboxane A2 (STA2), platelet-activating factor (PAF) and arginine-vasopressin, were inhibited by prior addition of 12-O-tetradecanoylphorbol 13-acetate (TPA) in time-dependent and concentration-dependent manners. The inhibitions were mostly reversed by staurosporine, and inhibitor of protein kinase C, added 1 min before TPA. Prior treatment of platelets with thrombin or STA2, the efficacious Ca2+ mobilizer, suppressed the increase in the intracellular Ca2+ concentration of the cells to other agonists, but treatment with less efficacious PAF or vasopressin did not. The heterologous receptor desensitizations were also reversed by staurosporine. The antibody, directed against the carboxy-terminal region of the alpha subunits 1 and 2 of the inhibitory guanine-nucleotide-binding proteins (Gi1 alpha and Gi2 alpha), was raised in rabbit and was used to immunoprecipitate Gi alpha in 32P-labeled platelets. The radioactivity was detected in Gi alpha after incubation of 32P-labeled platelets with TPA, thrombin or STA2, but not in the cells incubated with PAF or vasopressin. The time-dependency or concentration-dependency of TPA-induced phosphorylation of Gi alpha was similar to the dependency of its inhibitory action on agonist-induced Ca2+ mobilization. Thus, strong activation of Ca2+/phospholipid-dependent protein kinase C by phorbol ester or agonists of certain Ca(2+)-mobilizing receptors leads to phosphorylation of the alpha subunit of guanine-nucleotide-binding protein, thereby impairing the coupling of the G protein to receptors as a feedback regulatory component of the receptor-triggered intracellular Ca(2+)-mobilizing system.
凝血酶、9,11-环氧-11,12-甲撑血栓素A2(STA2)、血小板活化因子(PAF)和精氨酸加压素等受体激动剂所引起的人血小板细胞内Ca2+浓度升高,会被预先加入的12-O-十四酰佛波醇-13-乙酸酯(TPA)以时间和浓度依赖性方式所抑制。这些抑制作用大多可被在TPA加入前1分钟添加的蛋白激酶C抑制剂星形孢菌素逆转。用凝血酶或STA2(有效的Ca2+动员剂)预先处理血小板,可抑制细胞对其他激动剂的细胞内Ca2+浓度升高,但用效果较差的PAF或加压素处理则不会。异源受体脱敏也可被星形孢菌素逆转。针对抑制性鸟嘌呤核苷酸结合蛋白(Gi1α和Gi2α)的α亚基1和2的羧基末端区域的抗体在兔体内产生,并用于免疫沉淀32P标记血小板中的Giα。在用TPA、凝血酶或STA2孵育32P标记的血小板后,可在Giα中检测到放射性,但在用PAF或加压素孵育的细胞中则未检测到。TPA诱导的Giα磷酸化的时间依赖性或浓度依赖性与其对激动剂诱导的Ca2+动员的抑制作用的依赖性相似。因此,佛波酯或某些Ca(2+)动员受体的激动剂对Ca2+/磷脂依赖性蛋白激酶C的强烈激活会导致鸟嘌呤核苷酸结合蛋白的α亚基磷酸化,从而损害G蛋白与受体的偶联,作为受体触发的细胞内Ca(2+)动员系统的反馈调节成分。